Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2008 1
2010 1
2011 1
2012 2
2013 1
2014 2
2015 2
2016 3
2017 4
2018 3
2019 1
2020 5
2021 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients.
Nissen SE, Lincoff AM, Brennan D, Ray KK, Mason D, Kastelein JJP, Thompson PD, Libby P, Cho L, Plutzky J, Bays HE, Moriarty PM, Menon V, Grobbee DE, Louie MJ, Chen CF, Li N, Bloedon L, Robinson P, Horner M, Sasiela WJ, McCluskey J, Davey D, Fajardo-Campos P, Petrovic P, Fedacko J, Zmuda W, Lukyanov Y, Nicholls SJ; CLEAR Outcomes Investigators. Nissen SE, et al. N Engl J Med. 2023 Apr 13;388(15):1353-1364. doi: 10.1056/NEJMoa2215024. Epub 2023 Mar 4. N Engl J Med. 2023. PMID: 36876740 Clinical Trial.
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.
Hokusai-VTE Investigators; Büller HR, Décousus H, Grosso MA, Mercuri M, Middeldorp S, Prins MH, Raskob GE, Schellong SM, Schwocho L, Segers A, Shi M, Verhamme P, Wells P. Hokusai-VTE Investigators, et al. N Engl J Med. 2013 Oct 10;369(15):1406-15. doi: 10.1056/NEJMoa1306638. Epub 2013 Aug 31. N Engl J Med. 2013. PMID: 23991658 Free article. Clinical Trial.
Neutron Radiobiology and Dosimetry.
Stricklin DL, VanHorne-Sealy J, Rios CI, Scott Carnell LA, Taliaferro LP. Stricklin DL, et al. Radiat Res. 2021 May 1;195(5):480-496. doi: 10.1667/RADE-20-00213.1. Radiat Res. 2021. PMID: 33587743 Free PMC article.
Translational approaches for radiation risk assessment.
Al-Nabulsi I, Stricklin D. Al-Nabulsi I, et al. Among authors: stricklin d. Int J Radiat Biol. 2021;97(1):1. doi: 10.1080/09553002.2020.1851547. Epub 2020 Dec 15. Int J Radiat Biol. 2021. PMID: 33196339 No abstract available.
Risk assessment in international operations.
Stricklin DL. Stricklin DL. Toxicol Appl Pharmacol. 2008 Nov 15;233(1):107-9. doi: 10.1016/j.taap.2008.01.016. Epub 2008 Jan 31. Toxicol Appl Pharmacol. 2008. PMID: 18325560 Review.
Workshop Report on Atomic Bomb Dosimetry--Review of Dose Related Factors for the Evaluation of Exposures to Residual Radiation at Hiroshima and Nagasaki.
Kerr GD, Egbert SD, Al-Nabulsi I, Bailiff IK, Beck HL, Belukha IG, Cockayne JE, Cullings HM, Eckerman KF, Granovskaya E, Grant EJ, Hoshi M, Kaul DC, Kryuchkov V, Mannis D, Ohtaki M, Otani K, Shinkarev S, Simon SL, Spriggs GD, Stepanenko VF, Stricklin D, Weiss JF, Weitz RL, Woda C, Worthington PR, Yamamoto K, Young RW. Kerr GD, et al. Among authors: stricklin d. Health Phys. 2015 Dec;109(6):582-600. doi: 10.1097/HP.0000000000000395. Health Phys. 2015. PMID: 26509626 Review.
28 results